Screener
Pacific Biosciences of California PACB Business Segments — Gain (Loss) on Disposition of Assets
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| General and administrative | 14,901 | 16,659 | 30,276 | 36,751 |
| Impairment charges | — | — | — | 15,000 |
| Settlement charges | — | — | 15,400 | — |
| Gain on disposal of assets | — | — | (45,796) | — |
| Change in fair value of contingent consideration | — | — | — | (18,700) |
| Amortization of acquired intangible assets | 833 | 833 | 1,666 | 362,875 |
| Operating loss | (44,610) | (44,853) | (52,967) | (473,787) |
| Other (expense) income, net | (73) | 2,958 | 193 | 5,515 |
Item 1. Financial Statements (unaudited):
FAQ
- What is Pacific Biosciences of California's business segments — gain (loss) on disposition of assets?
- Pacific Biosciences of California (PACB) reported business segments — gain (loss) on disposition of assets of $0 in Q2 2026.
- What does business segments — gain (loss) on disposition of assets mean?
- This reflects the net financial impact from the sale or disposal of property, equipment, or other business assets. It provides insight into the company's capital recycling efforts and the efficiency of its asset management strategy.
Ask your AI about Pacific Biosciences of California's business segments — gain (loss) on disposition of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude